dr peter attia semaglutide New insights on GLP-1 agonists—Ozempic, Wegovy, Mounjaro, and more (AMA 64 sneak peek) Could GLP-1s impact aging and

"By their nature, compounded drugs are supposed to be temporary to fill a gap in the market

The food noise just disappeared." "What I appreciated was that this wasn't a med spa just handing me a prescription

I had done every single diet on the face of the planet and failed at every single one of them, she said

In summary, future clinical trials should prioritize enrolling individuals at risk, followed by those in the early stages of the disease, as this offers a higher likelihood of demonstrating neuroprotective and disease-modifying effects

Wegovy is in short supply because the manufacturer, Novo Nordisk, cant keep up with demand, according to the FDA

The medication is new